MiroBio, a University of Oxford spin-out, started its operations at the BioEscalator in May 2019.
The team has worked hard to produce very exciting results in the lab and has recently raised £27M in series A funding from international investors, enabling the company to scale up its team and operations. Having outgrown the BioEscalator and reached a sustainable size, the team has recently moved to The Oxford Science Park. They join another community of innovative companies, including other BioEscalator alumni.
Tim Funnell, VP, Operations of MiroBio, said, “The BioEscalator is a buzzing community of ambitious start-up biotechs and welcomed Mirobio when we were a team of just 2 people in 2019. The high-quality facilities, resources and support to grow a company were invaluable and we are now graduating as a company of 15 scientists to build our independent laboratories.”
Elodie Siney, Events and Marketing Manager, said, “MiroBio has great potential to have a huge impact on the treatment of debilitating auto-immune diseases. We wish the team all the best for the future and will follow their progress with keen interest.”
Or you can visit MiroBio's site by clicking on their logo from our companies page.